DESCRIPTIVE ANALYSIS OF ANEMIA MANAGEMENT IN HEMODIALYSIS PATIENTS AND ASSOCIATION WITH ITS QUALITY OF LIFE.

Abstract

Aim & Objectives: This study aims to conduct a descriptive analysis of anemia management approaches in hemodialysis patients and their association with quality of life (QOL). Specifically, it will assess the efficacy of iron supplementation and erythropoietin-stimulating agents (ESAs) in managing anemia, monitor patient responses to treatment, and evaluate the impact of anemia on QOL using a self-prepared questionnaire.

Methodology: The Cross-sectional study conducted over six months in the Dialysis Department Vivekanandha Medical Care Hospital, this Cross-Sectional study involved 54 patients diagnosed with CKD, selection based on inclusion and exclusion criteria. The enrolled patients were assessed for anemia management and health related quality of life by using AMQLAS self-prepared questionnaire for CKD patients who underwent in Baseline, follow up 1, follow up 2 and follow up 3.

Results: Out of 54 patients, only 48 patients of them participated in the follow up session. Among 48 patients 42 male patients (87.5%) were predominantly affected with CKD rather than female. The highest frequency of CKD was among the age group of 41-50 (22.9%), 51-60 (52.0%). Improvements in Quality of life were improved and statically significant results (< 0.004*).

Conclusion: Overall, the study underscores the importance of evaluating both clinical outcomes and quality of life in CKD patient undergoing maintenance hemodialysis. It suggests that while demographic factors like age and gender play a role in treatment efficacy and addressing quality of life are crucial for improving patients care and outcomes.